Copyright © 2026 Knight Sac Media. All rights reserved.https://www.siliconinvestor.com/subject.aspx?subjectid=1706 Cytel Corporation discovers, designs and develops immunotherapeutics, a new class of drugs for the treatment of inflammatory diseases, infectious diseases and cancer. Current price at $6.75 Opinions comments???https://www.siliconinvestor.com/images/Logo380x132.pnghttps://www.siliconinvestor.com/subject.aspx?subjectid=170638013210